Lung Cancer

1

A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations

Kim, Dong-Wan, Lee, Se-Hoon, Lee, Jong Seok, Lee, Myung Ah, Kang, Jin Hyoung, Kim, Si Young, Shin, Sang Won, Kim, Hoon-Kyo, Heo, Dae Seog

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 433 KB

english, 2011

2

Acknowledgement to Reviewers 2010

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 97 KB

english, 2011

3

Editorial Board

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 37 KB

english, 2011

4

Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy

Bölükbas, Servet, Manegold, Christian, Eberlein, Michael, Bergmann, Thomas, Fisseler-Eckhoff, Annette, Schirren, Joachim

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 377 KB

english, 2011

6

The function of IGF-IR in NNK-mediated lung tumorigenesis

Siwicky, Megan D., Petrik, James J., Moorehead, Roger A.

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 2.85 MB

english, 2011

7

Secretoglobin 3A2/uteroglobin-related protein 1 is a novel marker for pulmonary carcinoma in mice and humans

Kurotani, Reiko, Kumaki, Nobue, Naizhen, Xu, Ward, Jerrold M., Linnoila, R. Ilona, Kimura, Shioko

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 1.93 MB

english, 2011

8

A qualitative exploration of a respiratory distress symptom cluster in lung cancer: Cough, breathlessness and fatigue

Molassiotis, A., Lowe, M., Blackhall, F., Lorigan, P.

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 158 KB

english, 2011

9

Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases

Sun, Jong-Mu, Ahn, Jin Seok, Lee, Soohyeon, Kim, Jung A., Lee, Jeeyun, Park, Yeon Hee, Park, Hee Chul, Ahn, Myung-Ju, Ahn, Yong Chan, Park, Keunchil

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 231 KB

english, 2011

10

Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapy

Imamura, Yohei, Azuma, Koichi, Kurata, Seiji, Hattori, Satoshi, Sasada, Tetsuro, Kinoshita, Takashi, Okamoto, Masaki, Kawayama, Tomotaka, Kaida, Hayato, Ishibashi, Masatoshi, Aizawa, Hisamichi

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 291 KB

english, 2011

11

Suppression of hydroxyurea-induced centrosome amplification by NORE1A and down-regulation of NORE1A mRNA expression in non-small cell lung carcinoma

Shinmura, Kazuya, Tao, Hong, Nagura, Kiyoko, Goto, Masanori, Matsuura, Shun, Mochizuki, Takahiro, Suzuki, Kazuya, Tanahashi, Masayuki, Niwa, Hiroshi, Ogawa, Hiroshi, Sugimura, Haruhiko

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 1.19 MB

english, 2011

12

Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung

Tsuta, Koji, Raso, Maria G., Kalhor, Neda, Liu, Diane D., Wistuba, Ignacio I., Moran, Cesar A.

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 1.42 MB

english, 2011

13

PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy

Pu, Xia, Hildebrandt, Michelle A.T., Lu, Charles, Lin, Jie, Stewart, David J., Ye, Yuanqing, Gu, Jian, Spitz, Margaret R., Wu, Xifeng

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 281 KB

english, 2011

14

Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer

Su, Wen-Pin, Chen, Yen-Ting, Lai, Wu-Wei, Lin, Chien-Chung, Yan, Jing-Jou, Su, Wu-Chou

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 599 KB

english, 2011

15

A phase I study of nimotuzumab in combination with radiotherapy in stages IIB–IV non-small cell lung cancer unsuitable for radical therapy: Korean results

Choi, Hye Jin, Sohn, Joo Hyuk, Lee, Chang Geol, Shim, Hyo Sub, Lee, Ik-Jae, Yang, Woo Ick, Kwon, Ji Eun, Kim, Se Kyu, Park, Moo-Suk, Lee, Ju Hee, Kim, Joo Hang

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 261 KB

english, 2011

16

Health-related quality of life among early-stage, non-small cell, lung cancer survivors

Ostroff, Jamie S., Krebs, Paul, Coups, Elliot J., Burkhalter, Jack E., Feinstein, Marc B., Steingart, Richard M., Logue, Amy E., Park, Bernard J.

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 144 KB

english, 2011

17

A phase I study of S-1 with concurrent thoracic radiotherapy in elderly patients with localized advanced non-small cell lung cancer

Takigawa, Nagio, Kiura, Katsuyuki, Hotta, Katsuyuki, Hosokawa, Shinobu, Nogami, Naoyuki, Aoe, Keisuke, Gemba, Kenichi, Fujiwara, Keiichi, Harita, Shingo, Takemoto, Mitsuhiro, Himei, Kengo, Shinkai, Te

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 187 KB

english, 2011

18

The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias

Minegishi, Yuji, Sudoh, Junko, Kuribayasi, Hideaki, Mizutani, Hideki, Seike, Masahiro, Azuma, Arata, Yoshimura, Akinobu, Kudoh, Shoji, Gemma, Akihiko

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 214 KB

english, 2011

19

Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC

Chang, Alex

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 304 KB

english, 2011

20

Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation

Dişel, Umut, Öztuzcu, Serdar, Beşen, Ali Ayberk, Karadeniz, Cemile, Köse, Fatih, Sümbül, Ahmet Taner, Sezer, Ahmet, Nursal, Gül Nihal, Abalı, Hüseyin, Özyılkan, Özgür

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 632 KB

english, 2011

21

Mutation analysis of the FRK gene in non-small cell lung cancers

Jin, Guang, Jeon, Hyo-Sung, Yang, Enyue, Park, Jae Yong

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 212 KB

english, 2011

22

Surgery and mesothelioma: If not randomization, at least standardization and registration!

Pass, Harvey

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 94 KB

english, 2011

23

Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesothelioma

Amatori, S., Bagaloni, I., Viti, D., Fanelli, M.

Journal:

Lung Cancer

Year:

2011

Language:

english

File:

PDF, 345 KB

english, 2011

24

Corrigendum to “Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy” [Lung Cancer 69S1 (2010) S11–S18]

Giuliani, Giovanni, Grossi, Francesco, de Marinis, Filippo, Walzer, Stefan

Journal:

Lung Cancer

Year:

2011

File:

PDF, 72 KB

2011

Volume 71; Issue 1

A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations

Acknowledgement to Reviewers 2010

Editorial Board

Contents

Survival after trimodality therapy for malignant pleural mesothelioma: Radical Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and radiotherapy

The function of IGF-IR in NNK-mediated lung tumorigenesis

Secretoglobin 3A2/uteroglobin-related protein 1 is a novel marker for pulmonary carcinoma in mice and humans

A qualitative exploration of a respiratory distress symptom cluster in lung cancer: Cough, breathlessness and fatigue

Predictors of skeletal-related events in non-small cell lung cancer patients with bone metastases

Prognostic value of SUVmax measurements obtained by FDG-PET in patients with non-small cell lung cancer receiving chemotherapy

Suppression of hydroxyurea-induced centrosome amplification by NORE1A and down-regulation of NORE1A mRNA expression in non-small cell lung carcinoma

Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung

PI3K/PTEN/AKT/mTOR pathway genetic variation predicts toxicity and distant progression in lung cancer patients receiving platinum-based chemotherapy

Apolipoprotein E expression promotes lung adenocarcinoma proliferation and migration and as a potential survival marker in lung cancer

A phase I study of nimotuzumab in combination with radiotherapy in stages IIB–IV non-small cell lung cancer unsuitable for radical therapy: Korean results

Health-related quality of life among early-stage, non-small cell, lung cancer survivors

A phase I study of S-1 with concurrent thoracic radiotherapy in elderly patients with localized advanced non-small cell lung cancer

The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias

Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC

Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation

Mutation analysis of the FRK gene in non-small cell lung cancers

Surgery and mesothelioma: If not randomization, at least standardization and registration!

Premature senescence induced by DNA demethylating agent (Decitabine) as therapeutic option for malignant pleural mesothelioma

Corrigendum to “Cost-effectiveness analysis of bevacizumab versus pemetrexed for advanced non-squamous NSCLC in Italy” [Lung Cancer 69S1 (2010) S11–S18]